Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
基本信息
- 批准号:10394139
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-10 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
Increased development of research, education and outreach partnerships with the Marine
Environmental Science Consortium-Dauphin Island Sea Lab (DISL) will greatly contribute to
FDA's mission. The DISL is one of Alabama's most valuable assets. DISL was recently designated
as the Alabama Center of Excellence and adds immeasurably to the quality of life in the state
and beyond. The DISL network includes well-recognized scientists affiliated with 23 state-
sponsored institutions that enroll students worldwide in degree programs in classrooms,
laboratories, and education centers. The DISL, which houses nationally recognized education
programs, leading-edge research collaborations, innovative business partnerships and
environmental policy makers, seeks to maintain its diverse multidisciplinary exchanges with
FDA as part of its vibrant and productive research network. This collaboration increases the
intellectual capital and outreach opportunities of DISL and FDA research throughout the Gulf of
Mexico. The goals of the proposed project include: Increased scientific exchanges between
university faculty and staff and FDA scientists and staff; Increased educational opportunities for
qualified students (graduate), staff members and faculty members in the Parties' laboratories,
classroom and offices; Facilitation of joint meetings for education and research; Increased
research collaborations between university faculty and staff and FDA scientists and staff;
Increased research product outputs, including peer-reviewed publications, protocol
development, and scientific presentations; Development of cooperative international activities
including outreach; and Sharing of unique facilities and equipment for increased cost
efficiencies for scientific endeavors. The project also will develop joint efforts to obtain grants
and other extramural funds to support collaborative research and training as permitted under
appropriate statutory authority, promote the adoption of ecologically relevant science in the
development of resource restoration programs, and promote the importance of science in the
everyday lives of the citizens of the Gulf of Mexico coast.
To date, the program has graduated 4 PhD students and 2 MS students. Two additional PhD and
MS students are participating in ongoing projects. In addition, several interns have received
research experiences on projects through the training program. Products from the program
during the last 4 years have included more than 58 presentations, 5 peer-reviewed
publications, 1 funded derivative research proposal.
抽象的
增加与海军陆战队的研究,教育和外展伙伴关系的发展
环境科学财团 - 杜普芬岛海实验室(DIB)将大大贡献
FDA的使命。不喜欢是阿拉巴马州最有价值的资产之一。最近被指定
作为阿拉巴马州卓越中心,并不可估量地增加了该州的生活质量
及以后。不喜欢网络包括符合23个州的良好认可的科学家
赞助机构,全世界在课堂上招募学生的学位课程,
实验室和教育中心。不愿意在全国认可的教育
计划,领先的研究合作,创新的业务伙伴关系以及
环保政策制定者试图与
FDA是其充满活力和生产性研究网络的一部分。这种合作增加了
整个海湾的智力资本和外展的机会
墨西哥。拟议项目的目标包括:增加的科学交流
大学教职员工以及FDA科学家和员工;增加教育机会
合格的学生(研究生),当事人实验室的工作人员和教职员工,
教室和办公室;促进教育和研究的联合会议;增加
大学教职员工与FDA科学家和员工之间的研究合作;
增加了研究产品产出,包括经同行评审的出版物,协议
发展和科学演讲;合作国际活动的发展
包括宣传;并共享独特的设施和设备以增加成本
科学努力的效率。该项目还将制定共同的努力来获得赠款
以及其他壁外资金,以支持协作研究和培训
适当的法定权威,促进在生态相关科学中的采用
制定资源恢复计划,并促进科学在
墨西哥沿岸公民的日常生活。
迄今为止,该课程已毕业4个博士生和2名MS学生。另外两个博士学位和
MS学生正在进行正在进行的项目。此外,已经收到了几个实习生
通过培训计划进行项目的研究经验。该计划的产品
在过去的四年中,包括58多个演讲,5个同行评审
出版物,1项资助的衍生研究建议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruth Carmichael其他文献
Ruth Carmichael的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruth Carmichael', 18)}}的其他基金
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
10337634 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
9754604 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
10630082 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
10399130 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
9975129 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
Food & Drug Administration (FDA) and MESC/Dauphin Island Sea Lab Collaboration
食物
- 批准号:
9275656 - 财政年份:2016
- 资助金额:
$ 12.5万 - 项目类别:
相似国自然基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
- 批准号:82371102
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于医保战略性购买的国家药品价格谈判政策因果效应、长效机制及优化策略研究
- 批准号:72374167
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
药品网上零售即时配送的时空协同优化方法研究
- 批准号:72371044
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
- 批准号:42307496
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Closed-loop attention bias modification brain training for opioid use disorder
针对阿片类药物使用障碍的闭环注意偏差修正大脑训练
- 批准号:
10699099 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
NHERF1 regulates MRGPRX2/MrgprB2 responses in mast cells
NHERF1 调节肥大细胞中的 MRGPRX2/MrgprB2 反应
- 批准号:
10711042 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
先进的载玻片和光学活检工具来检测高风险口腔癌前病变
- 批准号:
10768888 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Cannabinoid type 2 receptors as a therapeutic target for substance use disorders
大麻素 2 型受体作为物质使用障碍的治疗靶点
- 批准号:
10606224 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别: